Ulrik Cordes

Company: Cbio

Job title: Founder, Chief Executive Officer

Seminars:

Reverting TIL Exhaustion to Generate a TIL Product with More Stemness-Like T-Cells & a Broader T-Cell Repertoire to Improve Clinical Outcome 1:30 pm

Mapping T-cell specificities against tumor associated and HPV-derived antigens in TIL therapy products in cervical cancer Key strategies for ex vivo enrichment of tumor-reactive TILs including reinvigorating exhausted TILs and selective expansion Arming T-cells against oxidative stress preserving killing functionality in the hostile tumor microenvironmentRead more

day: Conference Day Two - Track A - PM